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Abstract: The indiscriminate use of non-regulated skin lighteners among African populations has
raised health concerns due to the negative effects associated with skin lightener toxicity. For this reason,
there is a growing interest in the cosmetic development of plants and their metabolites as alternatives
to available chemical-derived skin lightening formulations. Approximately 90% of Africa’s population
depends on traditional medicine, and the continent’s biodiversity holds plant material with various
biological activities, thus attracting considerable research interest. This study aimed to review existing
evidence and document indigenous African plant species capable of inhibiting the enzyme tyrosinase
and melanogenesis for potential incorporation into skin lightening products. Literature search on
melanin biosynthesis, skin lightening, and tyrosinase inhibitors resulted in the identification of
35 plant species were distributed among 31 genera and 21 families across 15 African countries and
9 South African provinces. All plants identified in this study showed competent tyrosinase and
melanogenesis inhibitory capabilities. These results indicate that African plants have the potential to
serve as alternatives to current chemically-derived skin lighteners.
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1. Introduction
Melanin is a widespread natural pigment that is responsible for color in hair, skin, and eyes.
It provides protection against the deleterious effects of ultraviolet (UV) irradiation [1]. Melanogenesis
is the physiological process of melanin formation in which TYR, a copper-dependent enzyme,
initiates the first step. Tyrosinase catalyzes the rate-limiting step where L-tyrosine is converted
to L-3,4,-dihydroxyphenylalanine (L-DOPA), leading to the eventual formation of the pigment
(Illustrated by Scheme 1) [2–5]. Abnormal TYR activity leads to pigmentary disorders, such as
the abnormal accumulation of melanin (hyperpigmentation) that accounts for most dermatology
visits [6–8]. Skin lighteners can be divided by their mechanisms of action, such as inhibition of
tyrosinase transcription, inhibition of melanosome transfer, and accelerated epidermal turnover,
with the most common target being tyrosinase (TYR) inhibition [9,10]. By decreasing the activity and/or
expression of TYR, melanogenesis can be inhibited, leading to reduced melanin production [11].
Cosmetics 2020, 7, 60; doi:10.3390/cosmetics7030060 www.mdpi.com/journal/cosmetics
Cosmetics 2020, 7, 60 2 of 14Cosmetics 2020, 7, x FOR PEER REVIEW 2 of 14 
 
 
Scheme 1. Illustration of the melanogenesis pathway. 
The skin lightening industry is one of the fastest-growing segments of the global beauty 
industry. Global industry analysts (GIA) have predicted that by 2020, the universal skin lightening 
market will reach $23 billion [12]. A recent meta-analysis provided evidence of the global prevalence 
of skin lightening use by reporting an estimate of 27.7%, with Africa at a current estimated 
prevalence of 27.1% [13]. Previous epidemiological studies have also reported a high prevalence of 
skin lightener use among African populations. This is evident among South African, Senegalese, and 
Nigerian study populations that revealed between 32 to 75% skin lightener use [14–16]. 
This practice is motivated by a long-standing history of social divisions, including societal 
pressures and stigmas, leading to the demand for lighter skin tones [17,18]. Creams, lotions, soaps, 
and injections indicated as a treatment for hyperpigmentation disorders are exceedingly abused as 
self-medication to achieve a lighter skin complexion [19,20]. In many African countries, a variety of 
these skin lightening preparations are easily obtained over-the-counter without a medical 
prescription, despite this being a requirement by law [15,21]. The most frequently used ingredients 
include steroids, mercury, hydroquinone (HQ) (considered the gold standard), and its derivatives 
[7]. Health concerns associated with the long-term use of these skin lightener ingredients include 
exogenous ochronosis and infectious dermatosis [22,23]. Furthermore, heavy metal exposure can 
lead to damage to the circulatory and urinary systems [24]. Due to their toxicity, these compounds 
have been prohibited as skin lightening compounds in several African countries, including South 
Africa, Nigeria, Kenya, and the Ivory Coast [25,26]. Despite this ban, these damaging chemicals are 
often illegally introduced into cosmetic formulations and, the public continues to gain access via 
informal channels such as street vendors, markets, and non-pharmaceutical shops [27,28]. In 
contrast, botanicals and natural ingredients offer safer alternatives as they may not exhibit the same 
kind of toxicity as synthetic compounds and could exhibit much less harmful side effects [29]. 
Despite this, consumers are not generally aware that natural products are composed of a variety of 
chemical compounds that could lead to the development of some adverse reactions. These potential 
effects could be overcome by researchers chemically characterizing extracts with respect to its 
composition [30]. 
Botanicals and natural ingredients provide abundant sources of treatment for various diseases 
such as cancer, diabetes, and dermatological conditions [31,32]. The use of plants is a common 
practice in traditional medicines of many cultures using several plant extracts as cosmetics to 
improve skin health [33,34]. This could be attributed to plant extracts being a rich source of vitamins, 
antioxidants, oils/essential oils, and other bioactive compounds, which provide the body with 
nutrients necessary for healthy skin [30]. Plants also constitute a variety of chemical compounds that 
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The skin lightening industry is one of the fastest-growing segments of the global beauty industry.
Global industry analysts (GIA) have predicted that by 2020, the u iversal skin lightening market
will reach $23 billion [12]. A recent meta-analysis provided evidence of the global prevalence of ski
lightening use by reporting an estimate of 27.7%, with Africa at a current estimated prevalence of
27.1% [13]. Previous epidemiological studies have also reported a hig prevalence of skin lightener
use among African populations. This is evi ent among So th African, Senegalese, and Nigerian study
populations that revealed between 32 t 75% skin lightener use [14–16].
This practice is motivated by a long-standing history of social divisions, including societal
pressures and stigmas, leading to the dema d for lighter skin tones [17,18]. Creams, lotions, soaps,
and injections indicated as a treatment for hyperpigmentation disorders are exceedingly abused as
self-medication to achieve a lighter skin complexion [19,20]. In many African countries, a variety of
these skin lighteni g preparations are easily obtained over-the-cou ter without a medical prescription,
despite this being a requirement by law [15,21]. The most frequently used ingredients include steroids,
mercury, hydroquinone (HQ) (considered the gold standard), and its derivatives [7]. Health concerns
associated with the long-term use of these skin lightener ingredients include exogenous ochronosis
and infectious dermatosis [22,23]. Furthermore, heavy metal exposure can lead to damage to the
circulatory and urinary systems [24]. Due to their toxicity, these compounds have been prohibited
as skin lightening compounds in several African countries, including South Africa, Nigeria, Kenya,
and the Ivory Coast [25,26]. Despite this ban, these damaging chemicals are often illegally introduced
into cosmetic formulations and, the public continues to gain access via informal cha nels such as
street vendors, markets, an non-pharmaceutical shops [27,28]. In contrast, botanicals and natural
ingredients offer safer alternatives as they may not exhibit the same kind of toxicity as synthetic
compounds and could exhibit much less harmful side effects [29]. Despite this, consumers are not
generally aware that natural products are composed of a variety of chemical compounds that could
lead to the development of some adverse reactions. These potential effects could be overcome by
researchers che ically characterizing extracts with respect to its composition [30].
Botanicals and natural ingredients provide abundant sources of treatment for various diseases
such as cancer, diabetes, and dermatological conditions [31,32]. The use of plants is a common practice
in traditional medicines of many cultures using several plant extracts as cosmetics to improve skin
health [33,34]. This could be attributed to plant extracts being a rich source of vitamins, antioxidants,
oils/essential oils, and other bioactive compounds, which provide the body with nutrients necessary
for healthy skin [30]. Plants also constitute a variety of chemical compounds that elicit various
pharmacological activities with the possibility that these compounds act synergistically to produce a
Cosmetics 2020, 7, 60 3 of 14
net pharmacological effect [35]. Examples of such compounds include polyphenols and flavonoids.
Polyphenols are widely distributed in plants, and several polyphenol types have been reported as being
responsible for melanogenesis inhibition [36,37]. Flavonoids and chalcones are a group of polyphenols
with flavonoids being one of the most explored and most numerous groups of polyphenols [38].
Flavonoids are found within the leaves, seeds, bark, and flowers of most plants, and have been studied
for its oxidation of L-DOPA and have shown good antityrosinase. Furthermore, chalcones exhibit a
wide array of biological activities with a number of chalcones eliciting antityrosinase activity [39–41].
The significant advancement of research using plant extracts in cosmetics demonstrates the
growing interest of researchers and pharmaceutical companies in developing natural skin lightening
products [42]. The objective of this review was to examine existing literature to identify and document
indigenous African plant species capable of inhibiting the enzyme TYR and melanogenesis for possible
use as alternatives to current skin lightening formulations.
2. Materials and Methods
A computerized literature search was performed using the following databases: MEDLINE,
SCOPUS, GOOGLE SCHOLAR, MEDLINE EBSCOHOST, and SCIENCE DIRECT databases.
In addition, the South African National Electronic Thesis Database (ETD) was searched for grey
literature, which included Masters and Doctoral theses. The following key terms were used for the
retrieval of articles in the databases: “skin lightening”, “tyrosinase”, “melanin”, “antimelanogenesis”,
“antityrosinase”, “melanogenesis”, “tyrosinase inhibition”, “melanin inhibition”. For an article to
be considered eligible, the following criteria needed to be met: (1) The use of indigenous African
plant extracts (alone or in combination with other African plants); (2) performed in vivo and in vitro
studies only; (3) investigated tyrosinase and melanogenesis inhibition. This literature search also had
no restrictions on the following: Language; date of publication, and publication status (inclusive of
published, unpublished, in the press and in progress). Studies that reported on both non-African
(not indigenous to Africa and imported plants) and African plants were isolated, and only the African
plants were included in this study. In addition, studies that included tests other than tyrosinase
and melanin assays were isolated, and only the tyrosinase and melanin assays were reported on.
All qualitative studies were excluded. Three independent reviewers completed the above-described
methods independently. Any disagreements between the reviewers were discussed and resolved.
The articles that had been retrieved through the computerized literature searches were combined,
giving a total of 128 articles. A preliminary analysis of the titles and abstracts of each article was
performed, and all duplicates were excluded. After the screening of abstracts by at least 2 authors,
the articles classified as ineligible based on the previously described criteria were excluded, and a total
of 49 articles underwent a full-text review.
After further application of the exclusion and inclusion criteria, a total of 36 articles were classified
as eligible for discussion in this review. Tables 1 and 2 summarizes the plant species identified along
with their melanin and tyrosinase results, respectively. In both tables, the plant names are arranged
according to their family, along with the region the plants are found in Africa and plant part used.
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Table 1. Summary of the plant species identified and their melanin results.
Family Plant Name Region Part Used Results Reference
Anacardiaceae Harpephyllum caffrum SA (EC) LeavesBark 26% melanin inhibition at 6.25 µg/mL [32]
Chenopodiaceae Arthrophytum scoparium TUN Stems 52% melanin inhibition [43]
Clusiaceae Garcinia livingstonei Clusiaceae Bark isolated compounds,
<0.25 MC at 25 µg/mL [22]
Lamiaceae Salvia officinalis EGY Aerial parts MC at 27% at 10, 20 and 40 µg/mL [44]
Melianthaceae Greyia flanaganii SA (EC) Leaves 20% melanin inhibition at 6.25 µg/mL [4]
Melianthaceae Greyia radlkoferi SA (MP) Leaves isolated compound,50% melanin inhibition at 12.5 µg/mL [45]
Myrsinaceae Myrsine africana
SA
(EC, FS, GAU, KZN,
LP, MP, NW, WC)
Shoots 50% melanin inhibition at 50 µg/mL [46]
Myrsinaceae Myrsine africana
SA
(EC, FS, GAU, KZN,
LP, MP, NW, WC)
Shoots 18% melanin inhibition at 12.50 µg/mL [40]
Pedaliaceae Sesamum angolense RWA Leaves cell pellets indicate no significant inhibition [47]





Proteaceae Protea madiensis NIG, ETH Root bark cell pellets indicates strong inhibition [47]
Proteaceae Serruria furcellata SA (WC) Aerial parts 94.3% melanin inhibition at 50 µg/mL [48]
Rhizophoracea Cassipourea congoensis SEN, NIG, DRC, UGA, TZA, MLI Roots isolated compounds,
<0.2 pg/mL MC at 10 µg/mL and 100 µg/mL [49]
Rubiaceae Dolichopentas longiflora RWA LeavesRoots cell pellet indicate increase [47]
Sapotaceae Argania spinosa MAR Fruits 55% melanin inhibition at 50 µg/mL [50]
Sapotaceae Argania spinosa MAR Fruits >50% melanin inhibition at 1/100 [23]
Sapotaceae Sideroxylon inerme SA (KZN) Stem-bark 37% melanin inhibition at 6.2 µg/mL [33,51]
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Table 1. Cont.
Family Plant Name Region Part Used Results Reference
Sapotaceae Vitellaria paradoxa MLI, ETH, UGA Fruit
Cameroon = 10.1% MC at 100 µg/mL
Chad = 10.2% MC at 100 µg/mL
Sudan = 10.9% MC at 100 µg/mL
[52]
Thymelaeaceae Thymelaea hirsuta TUN Leaves >50% melanin inhibition of melanin [53]
Thymelaeaceae Thymelaea hirsuta TUN Leaves isolated compound,37% melanin inhibition at 0.1 µg/mL [54]
Thymelaeaceae Thymelaea hirsuta TUN Leaves
isolated compound,
50% melanin inhibition at 1 µg/mL
isolated compound,
33% melanin inhibitionat 0.1 µg/mL
[55]
This table indicates the melanin inhibition or MC (melanin content) at various concentrations of plant extracts (µg/mL). Provinces in South Africa (SA)—EC: Eastern Cape; FS: Free State;
GAU: Gauteng; KZN: KwaZulu-Natal; LP: Limpopo; MP: Mpumalanga; NW: North West; WC: Western Cape; Other African countries—ALG: Algeria; DRC: Democratic Republic of
Congo; EGY: Egypt; ETH: Ethiopia; GHA: Ghana; IC: Ivory Coast; MAR: Morocco; MLI: Malawi; NIG: Nigeria; RWA: Rwanda; SEN: Senegal; SUD: Sudan; TUN: Tunisia; TZA: Tanzania;
UGA: Uganda; -: not significant.
Table 2. Summary of the plant species identified and their tyrosinase results.
Family Plant Name Region Part Used Results (IC50 or Other Values) Reference
Anacardiaceae Harpephyllum caffrum SA (EC) LeavesBark
92% inhibition of L-tyrosine at 500 µg/mL
60% inhibition of L-DOPA at 500 µg/mL
IC50 40 ± 0.035 µg/mL
[32]
Anacardiaceae Hyaenanche globosa SA (EC) LeavesBark
L-DOPA at 500 µg/mL = 42% inhibition
L-tyrosine at 500 µg/mL = 92% inhibition
IC50 27.1 ± 042 µg/mL
[40]
Anacardiaceae Hyaenanche globosa SA (EC) LeavesBark 90.4% TYR inhibition at 200 µg/mL [56]
Apiaceae Pituranthos scoparius TUN Aerial parts IC50 125.01 ± 0.72 µg/mL using L-tyrosineIC50 270.51 ± 0.76 µg/mL using L-DOPA
[57]
Asteraceae Helichrysum niveum SA (WC) Aerial parts Isolated compound, 35.63 ± 4.67 µg/mL [58]
Brassiaceae Rorippa nasturtium-aquaticum SA (EC) Leaves IC50 22.24 µg/mL [59]
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Table 2. Cont.
Family Plant Name Region Part Used Results (IC50 or Other Values) Reference
Brassiaceae Rorippa nasturtium-aquaticum SA (EC) Leaves IC50 1.513 µg/mL [60]
Capparaceae Cleome arabica TUN Aerial parts IC50 124.4 ± 0.69 µg/mL L-tyrosineIC50 243.43 ± 2.71 µg/mL using L-DOPA
[57]
Chenopodiaceae Haloxylon articulatum ALG, MAR, TUN Shoot IC50 160 µg/mL using L-DOPA as substrateIC50 using L- tyrosine not significant
[57]
Clusiaceae Garcinia kola ALG Seed 79% TYR inhibition at 500 µg/mL [61]
Euphorbiaceae Macaranga hurifolia NIG, GHA LeavesStem bark
Leaf extracts = 159.42 mg KAE/g
Bark extracts = 160.42 mg KAE/g [62]
Fabaceae Ceratonia siliqua ALG Leaves crude extract, 50% TYR inhibition at 200 µg/mLisolate compounds, 90% TYR inhibition at 200 µg/mL [51]
Fabaceae Ormocarpum trichocarpum SA (KZN, LP, MP) LeavesStems IC50 2.95 ± 1.76 µg/mL using L-tyrosine [63]
Fabaceae Rhynchosia villosa SA (EC, KZN, MP) Root 56.40% TYR inhibition at 100 µg/mL [64]
Fabaceae Vachellia karroo
SA
(EC, FS, GAU, KZN,
MP, NC, NW, WC)
Roots IC50 6.84 µg/mL [63]




IC50 8.61 ± 0.94 µg/mL using L-tyrosine
pod extract,
98.3% TYR inhibition at 500 µg/mL
[36]
Fabaceae Acacia nilotica SUDSA (GAU, KZN, LP, MP, NW)
Pods
Bark IC50 12.97 ± 1.07 µg/mL [65]
Lamiaceae Plectranthus ecklonii SA (EC, KZN, MP) Aerial parts IC50 61.73 ± 2.69 µg/mL
>70% at 100 µg/mL [66]
Lamiaceae Plectranthus ecklonii SA (EC, KZN, MP) Aerial parts IC50 21.58 µg/mL [67]
Lamiaceae Salvia barrelieri ALG Aerial parts 27% TYR inhibition at 1.5 mg/mL [68]
Melianthaceae Greyia flanaganii SA (EC) Leaves 95% TYR inhibition at 200 µg/mLIsolated compound, IC50 17.86 µg/mL
[4]
Melianthaceae Bersama abyssinica IC Leaves 148.94 mg KAE/g [69]
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Table 2. Cont.
Family Plant Name Region Part Used Results (IC50 or Other Values) Reference




(EC, FS, GAU, KZN,
LP, MP, NW, WC)
Shoots IC50 0.12 ± 0.001 mg/mL [46]
Myrsinaceae Myrsine africana
SA
(EC, FS, GAU, KZN,
LP, MP, NW, WC)
Shoots
L-DOPA at 500 µg/mL = 62% inhibition
L-tyrosine at 500 µg/mL = 83% inhibition




(EC, FS, GAU, KZN,
LP, MP, NW, WC)
Shoots IC50 27.4 µg/mL using L-tyrosine [63]
Pedaliaceae Sesamum angolense RWA Leaves IC50 24 µg/mL [47]
Poaceae Sorghum bicolor TUN Stalk 40% TYR inhibition (in comparison to untreated control) [70]
Podocarpaceae Podocarpus elongates SA (KZN) Stems 74% TYR inhibition at 1 mg/mLEC50 = 0.14mg/mL
[35]
Proteaceae Protea madiensis NIG, ETH Root barkLeaves 31 ± 4 µg/mL [47]
Proteaceae Serruria furcellata SA (WC) Aerial parts 95.49% TYR inhibition at 200 µg/mL80.84% TYR inhibition at 50 µg/mL [48]
Rhizophoraceae Cassipourea congoensis SEN, NIG, DRC, UGA, TZA,MLI Roots
crude extract,
>80% TYR inhibition at 10 µg/mL and 100 µg/mL [49]
Rhizophoraceae Cassipourea flanaganii SA (EC, KZN) Bark IC50 22.24 ± 1.32 µg/mL [59]
Rhizophoraceae Cassipourea flanaganii SA (EC, KZN) Bark IC50 1.425 µg/mL [60]
Rubiaceae Dolichopentas longiflora RWA LeavesRoots IC50 26 ± 2 µg/mL [47]
Sapotaceae Sideroxylon inerme SA (KZN) Stem-bark 70% TYR inhibition at 200 µg/mL [33,51]
This table indicates TYR inhibition, EC50 (concentration at which the plant extract exhibits 50% of its maximum response) and IC50 (concentration at which half the original TYR activity
is inhibited) values of plant extracts (µg/mL or KAE/g; KA equivalent per grams or mg/mL). Provinces in South Africa (SA) - EC: Eastern Cape; FS: Free State; GAU: Gauteng; KZN:
KwaZulu-Natal; LP: Limpopo; MP: Mpumalanga; NW: North West; WC: Western Cape; Other African countries - ALG: Algeria; DRC: Democratic Republic of Congo; EGY: Egypt; ETH:
Ethiopia; GHA: Ghana; IC: Ivory Coast; MAR: Morocco; MLI: Malawi; NIG: Nigeria; RWA: Rwanda; SEN: Senegal; SUD: Sudan; TUN: Tunisia; TZA: Tanzania; UGA: Uganda.
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3. Results and Discussion
In this study, 35 plant species distributed across 31 genera and 21 families were identified as being
effective as TYR and melanogenesis inhibitors. In addition, the plants identified in this study were
distributed among 15 African countries and 9 South African provinces. 17 (47.2%) were found in
South Africa, with 19 (52.7%) found within other African countries. The most represented families were
Fabaceae (5 plant species), Melianthaceae (3 plant species), Sapotaceae (3 plant species), Chenopodiaceae
(2 plant species), Proteaceae (2 plant species), Clusiaceae (2 plant species), Rhizophoraceae (2 plant
species), and Lamiaceae (2 plant species). The rest of the families were represented with only 1 plant
species—Anacardiaceae, Apiaceae, Asteraceae, Brassiaceae, Capparaceae, Euphorbiaceae, Myrsinaceae,
Pedaliaceae, Picrodendraceae, Poaceae, Podocarpaceae, Rubiaceae, and Thymelaeaceae.
African forests are the world’s second-largest tropical reservoir holding very promising plant
materials with various biological activities, which has attracted considerable research interest [50].
Up to 90% of Africa’s human population depends directly on traditional medicine. Plants form
a central component of the African traditional healthcare system and is probably the oldest of all
therapeutic systems [71,72]. The importance of this resource can be illustrated by the comprehensive
list of African medicinal plants in which more than 5400 plant taxa and over 16,300 medicinal uses
for the plants have been identified. The use of plant extracts as topical treatments has been practiced
for many generations with extracts being used for the treatment of various skin ailments, including
wounds, skin infections, and inflammation [73,74]. The demand for cosmetic skin-lightening products
is growing, with predictions particular to Asia and Africa forecasting the beauty industry to be
worth an estimated $US 31.2 billion by 2024 [12,75]. This significant increase can also be accounted
for by the pleasant aromatics and the general consensus that plant extracts are safer than synthetic
products available. Thus, there is an ever-growing endeavour to explore plant-based melanogenesis
inhibitors [76,77].
Various plant extracts and compounds have been investigated for their anti-tyrosinase and
antimelanogenic effects [78]. Three methods are extensively used to study tyrosinase activity,
which includes 2 radiometric assays (tyrosinase hydroxylase and melanin formation activities) and
one spectrophotometric assay (dopa oxidase activity). Tyrosinase hydroxylase assay estimates
the tyrosinase hydroxylase activity of tyrosinase by measuring tritiated water released from
L-[3,5-3H]-tyrosine. The melanin formation activity assay estimates the radioactive melanin synthesized
from L-[U-14C]-tyrosine while the dopa oxidase activity measures the rate of dopachrome formation,
of which all three are in vitro assays [79]. These assays also include the use of positive controls
whose potencies are well-known, such as kojic acid (KA), to which the substance of interest can be
compared [80]. Results obtained from these assays are often presented in IC50 values, which refers to
the concentration of plant extract at which half the original TYR activity is inhibited [40].
As shown in the results described in Table 2, plants reported from the Fabaceae family were only
tested for their ability as TYR inhibitors, and all proved to be strong inhibitors. Further results obtained
by Lall et al. [65], supported the findings for Ormocarpum and Acacia nilotica, which demonstrated
the lowest IC50 value of 2.95 µg/mL and showed to have the highest TYR inhibition of 98.3%
(IC50 8.61 µg/mL), respectively [36,63]. Cassipourea congoensis demonstrated significant effects of
both crude extract and isolated compounds on melanin and TYR activity, respectively [49]. Rorippa
nasturtium-aquaticum (Brassiaceae) showed in studies conducted by both Thibane et al. [59,60], that the
extract is an effective TYR inhibitor (IC50 values of 22.24 and 1.513 µg/mL respectively) when compared
to the kojic acid (KA) control (19.38 and 1.421 µg/mL, respectively). It is also noted that KA is the most
prominent (91.7%, 33 articles) positive control used in the studies identified, due to its well-established
potency in literature [80]. Arbutin, a HQ derivative, was the second most common (35.3%, 12 articles)
used positive control as it is generally used in cosmetics as a hypopigmenting agent [81].
Studies on Thymelaea hirsuta (Thymelaeaceae) reported that this extract inhibited more than 50%
of melanin at 1 µg/mL [53]. Furthermore, isolated compounds of this extract indicated that melanin
production was reduced by 37% at 0.1 µg/mL, in comparison to its arbutin control, which only inhibited
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33% of melanin at a higher concentration—100 µg/mL [54]. These results are further supported
by Villareal et al. [55], who concluded that isolated compounds of Thymelaea hirsuta at 0.1 µg/mL
(33% reduction of MC) is as effective as arbutin, a common depigmenting agent, at 100 µg/mL.
Rhizophoraceae extracts (Cassipourea flanaganii and Cassipourea congoensis) exhibited compelling skin
lightening properties with IC50 values obtained from studies conducted on Cassipourea flanaganii,
which indicated values (1.425 µg/mL and 22.24 µg/mL, respectively) comparable to their KA controls
(1.421 µg/mL and 19.38 µg/mL, respectively) [48,49]. Argania spinosa (Sapotaceae) effectively inhibited
melanogenesis at 55% after 72 hours’ exposure [50]. These findings are supported by Villareal et al. [23],
showing that there is a greater than 50% reduction in melanin content after 72 hours of exposure.
Although significant results were obtained from separate studies, the difference in the result could
be attributed to the researchers investigating different parts of the same plant (Table 1) as well as
differences in plant preparation and assay protocols.
The plants in this study were distributed among 15 African countries with studies, including
data from 9 South African provinces. Twenty plants species were investigated using aerial
parts/leaves with these plants being collected in different regions of their respective countries and/or
provinces. Thus, in natural ecosystems, factors affecting the plant’s performance include climate, soil,
and geographic locations yielding various molecular complexes, thus, emphasizing the environment’s
crucial role in the metabolism of plants [82,83].
The results obtained from the TYR and melanin assays of Harpephyllum caffrum showed the bark
extract to have the highest inhibitory effect on TYR and melanin production in comparison to the leaf
extract of the same species [32]. These results are further corroborated by a review conducted by Lall
and Kishore. [84], where it was noted that Harpephyllum caffrum and Greyia flanaganii, among other
listed plants, showed promising pharmacological activities, a finding that warrants further scientific
investigation. Similar comparisons can be seen with Ceratonia siliqua concerning TYR activity where its
isolated compounds (90% inhibition) were shown to be a more potent TYR inhibitor than its crude
extract (50% inhibition) at the same concentrations (200 µg/mL).
Further comparisons can also be observed by the contrast in results obtained for TYR assays
from the use of substrates L-DOPA and L-tyrosine. Here, several plant extracts have proven to be
more effective in targeting the inhibition of the oxidation of either L-DOPA or L-tyrosine. This is
illustrated by the TYR assay results obtained for Haloxylon articulatum, Greyia radlkoferi, Pituranthos
scoparius, Myrsine africana, Hyaenanche globose, and Cleome Arabica [40,45,57]. Additional studies also
included extracts of Dolichopentas longiflora, where preparations exhibited a stimulatory response on
melanogenesis, whereas the IC50 value for TYR activity (26 ± µg/mL) showed contrasting results.
This included Sesamum angolense of the same study, where pellets of the cells that were treated
with the extract indicated no significant inhibition. However, the IC50 value (24 µg/mL) obtained
indicated that the plant extract can illicit an inhibitory response [64]. Due to the complexity of pigment
production, melanogenesis regulation takes place at different levels and various means of interference
are possible—providing a possible explanation for the above-described contrasting results [85,86].
Mechanisms of depigmenting include; (1) tyrosinase inhibition, (2) decrease in DOPA polymerase,
(3) induction of anti-inflammatory, and (4) anti-oxidant effects [87].
Extracts from the Lamiaceae family also proved to be effective inhibitors with Plectranthus ecklonii
showing an IC50 value of 21.58µg/mL with more than 70% TYR inhibition and Salvia officinalis decreasing
MC to 27% at various concentrations [44,66,67]. In addition, other plant extracts elicited a significant
inhibitory response on both melanin and TYR activities. These include Garcinia livingstonei and Garcinia
kola (Clustiaceae), Myrsine africana (Myrsinaceae), Protea madiensis, and Serruria furcellata—both from the
Proteaceae family and Sideroxylon inerme (Sapotaceae). Species from other families such as Clustiaceae
(Garcinia livingstonei and Garcinia kola) exhibited significant activities with G. livingstonei exhibiting
a large decrease of melanin concentration at 25 µg/mL and the seeds of G. kola inhibiting 79% of
tyrosinase at 500 µg/mL [22,61].
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4. Conclusions
Several studies have been conducted to identify inhibitors from both natural and synthetic sources,
and a number of research papers have been published and regularly updated in this aspect. This study
was conducted as a means of identifying plant-based skin lightening alternatives to the current toxic
substances. Despite the serious and life-threatening complications associated with the chronic use of
these products, the use of skin lighteners is still a widespread and common practice in several African
countries [88,89].
All plants identified in this study showed competent antimelanogenesis and antityrosinase
capabilities, with the most effective of the extracts being the following: Acacia nilotica, Cassipourea
congoensis, Cassipourea flanaganii, Garcinia kola, Greyia flanaganii, Greyia radlkoferi, Hyaenanche
globosa, Myrsine africana, Ormocarpum trichocarpum, Plectranthus ecklonii, Protea madiensis, Rorippa
nasturtium-aquaticum, Serruria furcellata, Sesamum angolense, and Vachellia karroo. The reproducibility of
the identified studies and interpretation of the results is limited by the inconsistencies in methodologies
and means of plant extraction in these studies. Other variables also include geographical location and
varied climate regions.
This review shows that plants of the African continent have the potential to act as melanin and
TYR inhibitors and can be used to replace synthetic and other derived chemicals. Although many of
these plants have been effective in their pigment reduction properties, plants are still known to cause
allergic reactions and elicit phototoxic effects [87]. This is due to natural products being a complex
mixture of chemical compounds, a fact often unknown to consumers. To combat this, extracts should
be chemically characterized with respect to the product composition [30]. In addition, it is imperative
that toxicity studies be conducted to establish a safe dose range. These findings could aid in the
production and commercialization of these plants in natural-based remedies for cosmetic and skincare
product industries.
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